Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Post by Youhillmanon Feb 05, 2021 9:13am
184 Views
Post# 32482267

February’s Corporate Presentation.....

February’s Corporate Presentation.....CRDL has had a nice run this week, would love to see it get above $5 this month....

CRDL's CP Is now on CRDL's website, the link is below....

The company milestones haven't changed, I'm hoping to get an update on Cortalex sales at Shoppers within the next 60 days. CRDL is offering a 40% discount to paediatric patients, a nice to see...

At Cortalex™, we are dedicated to supporting paediatric patients with accessing CBD for their needs. Eligible patients and their caretakers will receive 40% off their Cortalex ™ purchase by calling the Shoppers Cannabis Care team and placing the order for Cortalex™ with an agent. The Shoppers Cannabis Care team can be contacted toll free today at 1-844-633-2627 to speak with a Cortalex™-trained pharmacist to find out more.

https://www.cardiolrx.com/wp-content/uploads/2021/02/Cardiol-Therapeutics-Corporate-Presentation-February-2021.pdf
<< Previous
Bullboard Posts
Next >>